| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10486169 | Value in Health | 2015 | 8 Pages |
Abstract
Subject-assessed QOL-AD is less likely than proxy-assessed QOL-AD to respond to changes in clinical measures used to track progression in clinical trials of subjects with mild to moderate AD. Proxy-assessed HUI-3 assessments were more in line with other outcome assessments and could therefore be better outcome measures to evaluate clinical progression in mild to moderate AD.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Loretto PhD, Joel MA, Katja PhD, Jose DrPH, Chris PharmD, MS,